GLENMARK PHARMACEUTICALS
Back to All Ratios
|
GLENMARK PHARMACEUTICALS Last 5 Year Return on Capital Employed (ROCE) History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
ROCE(%) | 4.88 | 4.43 | 14.19 | 15.30 | 14.04 |
What is the latest Return on Capital Employed (ROCE) ratio of GLENMARK PHARMACEUTICALS ?
Year | Return on Capital Employed (ROCE) |
---|---|
Mar2024 | 4.88 |
Mar2023 | 4.43 |
Mar2022 | 14.19 |
Mar2021 | 15.30 |
Mar2020 | 14.04 |
How is Return on Capital Employed (ROCE) of GLENMARK PHARMACEUTICALS Trending?
Years | Return on Capital Employed (ROCE) | % Change | |
---|---|---|---|
Mar2024 | 4.88 | 10.16 | |
Mar2023 | 4.43 | -68.78 | |
Mar2022 | 14.19 | -7.25 | |
Mar2021 | 15.3 | 8.97 | |
Mar2020 | 14.04 | - |
Other Financial Ratios of GLENMARK PHARMACEUTICALS
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Capital Employed (ROCE) ratio of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹43,540.6 Cr | 1.5% | 17.6% | 54.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹424,706.0 Cr | 2.3% | 11.7% | 5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,946.0 Cr | -1.6% | 4% | 58.7% | Stock Analytics | |
CIPLA | ₹120,751.0 Cr | 0.8% | 6.2% | -2.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,988.0 Cr | 0.7% | 9.8% | 19.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,066.7 Cr | -1% | 2.8% | -8% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | 1.5% |
17.6% |
54.5% |
SENSEX | -1.3% |
4.2% |
3.6% |
You may also like the below Video Courses